6827.TWO
Price:
$12.05
Market Cap:
$958.26M
MegaPro Biomedical Co., Ltd, a biotech company, focuses on the development of nano drugs. It also develops MPB-1523, an IOP injection that is in Phase II clinical trial for use in the treatment of hepatocellular carcinoma; and MPB-1514, an iron injection that is in Phase II clinical trial for use in the treatment of iron deficiency anemia, as well as MPB-1734, an anti-cancer drug that is in preclinical trial for the treatment of malignant tumor. The company was founded in 2014 and is based in Zhubei, Taiwan.
Industry
Biotechnology
IPO Date
2021-10-19
Stock Exchange
TWO
Ticker
6827.TWO
According to MegaPro Biomedical Co., Ltd’s latest financial reports and current stock price. The company's current ROE is -91.17%. This represents a change of 152.88% compared to the average of -36.05% of the last 4 quarters.
The mean historical ROE of MegaPro Biomedical Co., Ltd over the last ten years is -40.93%. The current -91.17% ROE has changed 122.72% with respect to the historical average. Over the past ten years (40 quarters), 6827.TWO's ROE was at its highest in in the December 2022 quarter at -15.73%. The ROE was at its lowest in in the June 2025 quarter at -50.36%.
Average
-40.93%
Median
-41.47%
Minimum
-80.27%
Maximum
0%
Discovering the peaks and valleys of MegaPro Biomedical Co., Ltd ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 69.34%
Maximum Annual ROE = 0%
Minimum Annual Increase = -Infinity%
Minimum Annual ROE = -80.27%
| Year | ROE | Change |
|---|---|---|
| 2024 | -80.27% | 69.34% |
| 2023 | -47.40% | 33.37% |
| 2022 | -35.54% | 61.80% |
| 2021 | -21.97% | -63.64% |
| 2020 | -60.42% | -Infinity% |
The current ROE of MegaPro Biomedical Co., Ltd (6827.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-54.41%
5-year avg
-49.12%
10-year avg
-40.93%
MegaPro Biomedical Co., Ltd’s ROE is greater than LabTurbo Biotech Corporation (-12.54%), greater than Bio Preventive Medicine Corp. (-24.73%), greater than GeneReach Biotechnology Corp. (-22.70%), greater than LAUNXP Biomedical Co., Ltd (-56.54%), greater than Lukas Biomedical Inc. (-31.59%), greater than Great Novel Therapeutics Biotech & Medicals (-14.66%), greater than Enimmune corporation (-70.32%), greater than NeoCore Technology Co., Ltd. (-6.78%), greater than NaviFUS Corp. (-20.42%), less than Taiwan Advance Bio-Pharmaceutical Inc. (9.19%),
| Company | ROE | Market cap |
|---|---|---|
| -12.54% | $1.12B | |
| -24.73% | $1.12B | |
| -22.70% | $1.12B | |
| -56.54% | $1.12B | |
| -31.59% | $1.29B | |
| -14.66% | $1.52B | |
| -70.32% | $1.48B | |
| -6.78% | $1.59B | |
| -20.42% | $1.44B | |
| 9.19% | $1.00B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MegaPro Biomedical Co., Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like MegaPro Biomedical Co., Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is MegaPro Biomedical Co., Ltd's ROE?
How is the ROE calculated for MegaPro Biomedical Co., Ltd (6827.TWO)?
What is the highest ROE for MegaPro Biomedical Co., Ltd (6827.TWO)?
What is the 3-year average ROE for MegaPro Biomedical Co., Ltd (6827.TWO)?
What is the 5-year average ROE for MegaPro Biomedical Co., Ltd (6827.TWO)?
How does the current ROE for MegaPro Biomedical Co., Ltd (6827.TWO) compare to its historical average?